Clinical Performance and Safety of Suture-TOOL
3 other identifiers
interventional
38
1 country
1
Brief Summary
The goal of this single arm intervention study is to investigate the safety and performance of a suturing device for closure of the midline incision after open abdominal surgery. The study population consists of 38 patients selected for open abdominal procedures for malignant and benign colorectal disease. The main question it aims to answer is: • If the device facilitates a Suture-Length to Wound-Length (SL/WL) ratio of 4:1 Participants laparotomy wound will be closed with the device at the end of the operation and closure related data as closure time and SL/WL ratio will be calculated. The wound will be assessed for infection during the postoperative stay and the chart will be reviewed for wound dehiscence and wound infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2023
CompletedStudy Start
First participant enrolled
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
January 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedJanuary 23, 2023
January 1, 2023
8 months
January 9, 2023
January 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients with Suture length/Wound length (SL/WL) ratio ≥ 4
SL/WL-ratio of patients laparotomy closures will be calculated by measuring (centimeter) and dividing the length of used suture with the length of the laparotomy wound.
Measured during laparotomy closure.
Secondary Outcomes (5)
Stitch count
Measured during laparotomy closure
Numbers of sutures used
Counted during laparotomy closure
Incision closure time
Measured during laparotomy closure
Surgeons´ comfort with device during closure
After laparotomy closure
Surgeons´ satisfaction with final closure result
After laparotomy closure
Other Outcomes (10)
Incision not following the midline (exposure of rectus muscle)
During the whole study period of up to 8 months
Thickness of subcutaneous fat
During the whole study period of up to 8 months
Glove punctures
During the whole study period of up to 8 months
- +7 more other outcomes
Study Arms (1)
Single arm
EXPERIMENTALClosure of the abdomen after laparotomy with Suture-TOOL.
Interventions
Eligibility Criteria
You may qualify if:
- Sex, age: male and female patients, ≥ 18 years old
- Surgery: elective open abdominal surgery for benign or malignant colorectal disease through midline incision.
- Anticipated incision length ≥ 12 cm
- Body Mass Index (BMI): 18 - 40 kg/m2 inclusive
- Full comprehension: ability to comprehend the full nature and purpose of the investigation, including possible risks and side effects; ability to co-operate with the Investigator and to comply with the requirements of the entire investigation.
You may not qualify if:
- Abdominal Surgery: previous abdominal surgery involving the midline
- Physical findings: clinically significant abnormal physical findings which could interfere with the objectives of the investigation according to the Investigator's opinion; existing midline hernia, cutaneous infection, fistula, psoriasis of abdominal skin; morbidly obese patients
- Pre-operative findings: any pre-operative findings identified by the surgeon/Investigator that may preclude the conduct of the investigation procedures
- Allergy: history of anaphylaxis to drugs or allergic reactions in general, which the Investigator considers could affect the outcome of the investigation
- Diseases: known or identified at surgery disseminated cancer disease; collagen diseases and immune deficiency disorders, according to the Investigator's opinion. Significant history of renal, hepatic, gastrointestinal, cardiovascular, respiratory, skin, haematological, endocrine or neurological diseases that according to the Investigator's opinion may interfere with the aim of the investigation
- Life expectancy: life expectancy less than 1 year
- Medications: any medication that could interfere with the investigation procedures or investigation outcome, according to the Investigator's opinion. Hormonal contraceptives for women are allowed
- Pregnancy and lactation: positive pregnancy test at screening (if applicable); pregnant or breastfeeding women
- Vulnerable subjects: Individuals unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response (ISO 14155:2020 §3.55) will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Suturion ABlead
- Helsingborgs Hospitalcollaborator
- Cross Research S.A.collaborator
Study Sites (1)
Helsingborgs Hospital
Helsingborg, Skåne County, 25187, Sweden
Related Publications (2)
Borner G, Montgomery A. Suture-Tool: A Mechanical Needle Driver for Standardized Wound Closure. World J Surg. 2020 Jan;44(1):95-99. doi: 10.1007/s00268-019-05179-5.
PMID: 31549201RESULTBorner G, Edelhamre M, Rogmark P, Montgomery A. Suture-TOOL: A suturing device for swift and standardized abdominal aponeurosis closure. Surg Pract Sci. 2022 Oct 5;11:100137. doi: 10.1016/j.sipas.2022.100137. eCollection 2022 Dec.
PMID: 39845163RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcus Edelhamre, MD Phd
Region Skåne
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2023
First Posted
January 23, 2023
Study Start
January 10, 2023
Primary Completion
August 30, 2023
Study Completion
August 30, 2023
Last Updated
January 23, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share